Global and China Recombinant Human Coagulation VIIa Market Status and Forecast 2022-2028

Global and China Recombinant Human Coagulation VIIa Market Status and Forecast 2022-2028

Market Analysis and Insights: Global Recombinant Human Coagulation VIIa and China Market
Due to the COVID-19 pandemic, the global Recombinant Human Coagulation VIIa market size is estimated to be worth US$ 1180 million in 2022 and is forecast to a readjusted size of US$ 1467 million by 2028 with a CAGR of 3.7% during the forecast period 2022-2028.
China Recombinant Human Coagulation VIIa market size was US$ 29.1 million in 2021, while the North America was US$ 507.26 million. The proportion of the China was 2.57% in 2021, while North America percentage was 44.74%.
The global major manufacturers of Recombinant Human Coagulation VIIa include Novo Nordisk, GENERIUM , LFB SA HEMA Biologics, AryoGen Pharmed, etc. In terms of revenue, the global three largest players hold a 99.16% market share of Recombinant Human Coagulation VIIa in 2021.
Global Recombinant Human Coagulation VIIa Scope and Market Size
Recombinant Human Coagulation VIIa market is segmented by region (country), by players, by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant Human Coagulation VIIa market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

For China market, this report focuses on the Recombinant Human Coagulation VIIa market size by players, by Type, and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in China.

The Key manufacturers that are operating in the global Recombinant Human Coagulation VIIa market are:
Novo Nordisk
GENERIUM
LFB SA HEMA Biologics
AryoGen Pharmed

Segment by Type
Vial
Prefilled Syringe

Segment by Application
Congenital Hemophilia
Acquired Hemophilia
Other

Segment by Region
North America
Europe
Japan & Korea
China
India
Latin America